Cadrenal's Pipeline Looks Less Like a Microcap and More Like an Emergency Response System
Cadrenal Is Rebuilding the Parts of Anticoagulation Everyone Else Gave Up On
Cadrenal's Quiet Expansion Play Is Starting to Get Loud
Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market